APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anaesthetic Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global General Anaesthetic Medication Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchGeneral Anaesthetic Medication Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anaesthetic Medication Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal General Anaesthetic Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anaesthetic Medication Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anaesthetic Medication Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global General Anaesthetic Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for General Anaesthetic Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for General Anaesthetic Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for General Anaesthetic Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for General Anaesthetic Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of General Anaesthetic Medication include Aspen Pharma, Hikma Pharmaceuticals, Maruishi, Piramal, AbbVie, Baxter Healthcare, B.Braun, Fresenius-Kabi and Hengrui, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for General Anaesthetic Medication, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of General Anaesthetic Medication, also provides the revenue of main regions and countries. Of the upcoming market potential for General Anaesthetic Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the General Anaesthetic Medication revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global General Anaesthetic Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for General Anaesthetic Medication revenue, projected growth trends, production technology, application and end-user industry.

General Anaesthetic Medication Segment by Company

Aspen Pharma

Hikma Pharmaceuticals

Maruishi

Piramal

AbbVie

Baxter Healthcare

B.Braun

Fresenius-Kabi

Hengrui

Nhwa

Xi'an Libang

Yichang Humanwell

General Anaesthetic Medication Segment by Type

Isoflurane

Etomidate

Remifentanil

Sevoflurane

Propofol

Other

General Anaesthetic Medication Segment by Application

Intravenous Anesthetics

Inhalational Anesthetics

General Anaesthetic Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anaesthetic Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anaesthetic Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anaesthetic Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of General Anaesthetic Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of General Anaesthetic Medication company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, General Anaesthetic Medication revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global General Anaesthetic Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Isoflurane Major Player Table 3. Etomidate Major Player Table 4. Remifentanil Major Player Table 5. Sevoflurane Major Player Table 6. Propofol Major Player Table 7. Other Major Player Table 8. Global General Anaesthetic Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Intravenous Anesthetics Major Player Table 10. Inhalational Anesthetics Major Player Table 11. General Anaesthetic Medication Industry Trends Table 12. General Anaesthetic Medication Industry Drivers Table 13. General Anaesthetic Medication Industry Opportunities and Challenges Table 14. General Anaesthetic Medication Industry Restraints Table 15. Global General Anaesthetic Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global General Anaesthetic Medication Market Size by Region (2021-2026) & (US$ Million) Table 17. Global General Anaesthetic Medication Market Share by Region (2021-2026) Table 18. Global General Anaesthetic Medication Market Size by Region (2027-2032) & (US$ Million) Table 19. Global General Anaesthetic Medication Market Share by Region (2027-2032) Table 20. Global General Anaesthetic Medication Revenue by Players (US$ Million) & (2021-2026) Table 21. Global General Anaesthetic Medication Revenue Market Share by Players (2021-2026) Table 22. Global General Anaesthetic Medication Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global General Anaesthetic Medication Key Players Headquarters & Area Served Table 24. Global General Anaesthetic Medication Players, Product Type & Application Table 25. Global General Anaesthetic Medication Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global General Anaesthetic Medication by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global General Anaesthetic Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global General Anaesthetic Medication Revenue by Type (2021-2026) & (US$ Million) Table 30. Global General Anaesthetic Medication Revenue by Type (2027-2032) & (US$ Million) Table 31. Global General Anaesthetic Medication Revenue Market Share by Type (2021-2026) Table 32. Global General Anaesthetic Medication Revenue Market Share by Type (2027-2032) Table 33. Global General Anaesthetic Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global General Anaesthetic Medication Revenue by Application (2021-2026) & (US$ Million) Table 35. Global General Anaesthetic Medication Revenue by Application (2027-2032) & (US$ Million) Table 36. Global General Anaesthetic Medication Revenue Market Share by Application (2021-2026) Table 37. Global General Anaesthetic Medication Revenue Market Share by Application (2027-2032) Table 38. Aspen Pharma Company Information Table 39. Aspen Pharma Business Overview Table 40. Aspen Pharma General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Aspen Pharma General Anaesthetic Medication Product Portfolio Table 42. Aspen Pharma Recent Development Table 43. Hikma Pharmaceuticals Company Information Table 44. Hikma Pharmaceuticals Business Overview Table 45. Hikma Pharmaceuticals General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Hikma Pharmaceuticals General Anaesthetic Medication Product Portfolio Table 47. Hikma Pharmaceuticals Recent Development Table 48. Maruishi Company Information Table 49. Maruishi Business Overview Table 50. Maruishi General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Maruishi General Anaesthetic Medication Product Portfolio Table 52. Maruishi Recent Development Table 53. Piramal Company Information Table 54. Piramal Business Overview Table 55. Piramal General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Piramal General Anaesthetic Medication Product Portfolio Table 57. Piramal Recent Development Table 58. AbbVie Company Information Table 59. AbbVie Business Overview Table 60. AbbVie General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. AbbVie General Anaesthetic Medication Product Portfolio Table 62. AbbVie Recent Development Table 63. Baxter Healthcare Company Information Table 64. Baxter Healthcare Business Overview Table 65. Baxter Healthcare General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Baxter Healthcare General Anaesthetic Medication Product Portfolio Table 67. Baxter Healthcare Recent Development Table 68. B.Braun Company Information Table 69. B.Braun Business Overview Table 70. B.Braun General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. B.Braun General Anaesthetic Medication Product Portfolio Table 72. B.Braun Recent Development Table 73. Fresenius-Kabi Company Information Table 74. Fresenius-Kabi Business Overview Table 75. Fresenius-Kabi General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Fresenius-Kabi General Anaesthetic Medication Product Portfolio Table 77. Fresenius-Kabi Recent Development Table 78. Hengrui Company Information Table 79. Hengrui Business Overview Table 80. Hengrui General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Hengrui General Anaesthetic Medication Product Portfolio Table 82. Hengrui Recent Development Table 83. Nhwa Company Information Table 84. Nhwa Business Overview Table 85. Nhwa General Anaesthetic Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Nhwa General Anaesthetic Medication Product Portfolio Table 87. Nhwa Recent Development Table 88. Xi'an Libang Company Information Table 89. Xi'an Libang Business Overview Table 90. Xi'an Libang General Anaesthetic Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Xi'an Libang General Anaesthetic Medication Product Portfolio Table 92. Xi'an Libang Recent Development Table 93. Yichang Humanwell Company Information Table 94. Yichang Humanwell Business Overview Table 95. Yichang Humanwell General Anaesthetic Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Yichang Humanwell General Anaesthetic Medication Product Portfolio Table 97. Yichang Humanwell Recent Development Table 98. North America General Anaesthetic Medication Revenue by Type (2021-2026) & (US$ Million) Table 99. North America General Anaesthetic Medication Revenue by Type (2027-2032) & (US$ Million) Table 100. North America General Anaesthetic Medication Revenue by Application (2021-2026) & (US$ Million) Table 101. North America General Anaesthetic Medication Revenue by Application (2027-2032) & (US$ Million) Table 102. North America General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America General Anaesthetic Medication Revenue by Country (2021-2026) & (US$ Million) Table 104. North America General Anaesthetic Medication Revenue by Country (US$ Million) & (2027-2032) Table 105. Europe General Anaesthetic Medication Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe General Anaesthetic Medication Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe General Anaesthetic Medication Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe General Anaesthetic Medication Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe General Anaesthetic Medication Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe General Anaesthetic Medication Revenue by Country (US$ Million) & (2027-2032) Table 112. China General Anaesthetic Medication Revenue by Type (2021-2026) & (US$ Million) Table 113. China General Anaesthetic Medication Revenue by Type (2027-2032) & (US$ Million) Table 114. China General Anaesthetic Medication Revenue by Application (2021-2026) & (US$ Million) Table 115. China General Anaesthetic Medication Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia General Anaesthetic Medication Revenue by Type (2021-2026) & (US$ Million) Table 117. Asia General Anaesthetic Medication Revenue by Type (2027-2032) & (US$ Million) Table 118. Asia General Anaesthetic Medication Revenue by Application (2021-2026) & (US$ Million) Table 119. Asia General Anaesthetic Medication Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia General Anaesthetic Medication Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Asia General Anaesthetic Medication Revenue by Region (US$ Million) & (2021-2026) Table 122. Asia General Anaesthetic Medication Revenue by Region (US$ Million) & (2027-2032) Table 123. SAMEA General Anaesthetic Medication Revenue by Type (2021-2026) & (US$ Million) Table 124. SAMEA General Anaesthetic Medication Revenue by Type (2027-2032) & (US$ Million) Table 125. SAMEA General Anaesthetic Medication Revenue by Application (2021-2026) & (US$ Million) Table 126. SAMEA General Anaesthetic Medication Revenue by Application (2027-2032) & (US$ Million) Table 127. SAMEA General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. SAMEA General Anaesthetic Medication Revenue by Country (2021-2026) & (US$ Million) Table 129. SAMEA General Anaesthetic Medication Revenue by Country (US$ Million) & (2027-2032) Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. General Anaesthetic Medication Image Figure 2. Global General Anaesthetic Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anaesthetic Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Isoflurane Image Figure 5. Etomidate Image Figure 6. Remifentanil Image Figure 7. Sevoflurane Image Figure 8. Propofol Image Figure 9. Other Image Figure 10. Global General Anaesthetic Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global General Anaesthetic Medication Market Size Share 2021 VS 2025 VS 2032 Figure 12. Intravenous Anesthetics Image Figure 13. Inhalational Anesthetics Image Figure 14. Global General Anaesthetic Medication Market Size (US$ Million) & (2021-2032) Figure 15. Global General Anaesthetic Medication Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global General Anaesthetic Medication Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global General Anaesthetic Medication Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global General Anaesthetic Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global General Anaesthetic Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global General Anaesthetic Medication Revenue Market Share by Type (2021-2032) Figure 22. Global General Anaesthetic Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global General Anaesthetic Medication Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global General Anaesthetic Medication Revenue Market Share by Application (2021-2032) Figure 25. North America General Anaesthetic Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America General Anaesthetic Medication Revenue Share by Type (2021-2032) Figure 27. North America General Anaesthetic Medication Revenue Share by Application (2021-2032) Figure 28. North America General Anaesthetic Medication Revenue Share by Country (2021-2032) Figure 29. United States General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe General Anaesthetic Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe General Anaesthetic Medication Revenue Share by Type (2021-2032) Figure 34. Europe General Anaesthetic Medication Revenue Share by Application (2021-2032) Figure 35. Europe General Anaesthetic Medication Revenue Share by Country (2021-2032) Figure 36. Germany General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China General Anaesthetic Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China General Anaesthetic Medication Revenue Share by Type (2021-2032) Figure 46. China General Anaesthetic Medication Revenue Share by Application (2021-2032) Figure 47. Asia General Anaesthetic Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia General Anaesthetic Medication Revenue Share by Type (2021-2032) Figure 49. Asia General Anaesthetic Medication Revenue Share by Application (2021-2032) Figure 50. Asia General Anaesthetic Medication Revenue Share by Region (2021-2032) Figure 51. Japan General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA General Anaesthetic Medication Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA General Anaesthetic Medication Revenue Share by Type (2021-2032) Figure 59. SAMEA General Anaesthetic Medication Revenue Share by Application (2021-2032) Figure 60. SAMEA General Anaesthetic Medication Revenue Share by Country (2021-2032) Figure 61. Brazil General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt General Anaesthetic Medication Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Etomidate
  • Remifentanil
  • Sevoflurane
  • Propofol
  • Other
Applications
  • Intravenous Anesthetics
  • Inhalational Anesthetics
Companies covered
  • Aspen Pharma
  • Hikma Pharmaceuticals
  • Maruishi
  • Piramal
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Fresenius-Kabi
  • Hengrui
  • Nhwa
  • Xi'an Libang
  • Yichang Humanwell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 General Anaesthetic Medication Market by Type
  3. 1.2.1 Global General Anaesthetic Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Isoflurane
  5. 1.2.3 Etomidate
  6. 1.2.4 Remifentanil
  7. 1.2.5 Sevoflurane
  8. 1.2.6 Propofol
  9. 1.2.7 Other
  10. 1.3 General Anaesthetic Medication Market by Application
  11. 1.3.1 Global General Anaesthetic Medication Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Intravenous Anesthetics
  13. 1.3.3 Inhalational Anesthetics
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 General Anaesthetic Medication Market Dynamics
  1. 2.1 General Anaesthetic Medication Industry Trends
  2. 2.2 General Anaesthetic Medication Industry Drivers
  3. 2.3 General Anaesthetic Medication Industry Opportunities and Challenges
  4. 2.4 General Anaesthetic Medication Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global General Anaesthetic Medication Market Perspective (2021-2032)
  2. 3.2 Global General Anaesthetic Medication Growth Trends by Region
  3. 3.2.1 Global General Anaesthetic Medication Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global General Anaesthetic Medication Market Size by Region (2021-2026)
  5. 3.2.3 Global General Anaesthetic Medication Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global General Anaesthetic Medication Revenue by Players
  2. 4.1.1 Global General Anaesthetic Medication Revenue by Players (2021-2026)
  3. 4.1.2 Global General Anaesthetic Medication Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global General Anaesthetic Medication Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global General Anaesthetic Medication Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global General Anaesthetic Medication Key Players Headquarters & Area Served
  7. 4.4 Global General Anaesthetic Medication Players, Product Type & Application
  8. 4.5 Global General Anaesthetic Medication Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global General Anaesthetic Medication Market CR5 and HHI
  11. 4.6.3 2025 General Anaesthetic Medication Tier 1, Tier 2, and Tier 3
5 General Anaesthetic Medication Market Size by Type
  1. 5.1 Global General Anaesthetic Medication Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global General Anaesthetic Medication Revenue by Type (2021-2032)
  3. 5.3 Global General Anaesthetic Medication Revenue Market Share by Type (2021-2032)
6 General Anaesthetic Medication Market Size by Application
  1. 6.1 Global General Anaesthetic Medication Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global General Anaesthetic Medication Revenue by Application (2021-2032)
  3. 6.3 Global General Anaesthetic Medication Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aspen Pharma
  2. 7.1.1 Aspen Pharma Company Information
  3. 7.1.2 Aspen Pharma Business Overview
  4. 7.1.3 Aspen Pharma General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aspen Pharma General Anaesthetic Medication Product Portfolio
  6. 7.1.5 Aspen Pharma Recent Developments
  7. 7.2 Hikma Pharmaceuticals
  8. 7.2.1 Hikma Pharmaceuticals Company Information
  9. 7.2.2 Hikma Pharmaceuticals Business Overview
  10. 7.2.3 Hikma Pharmaceuticals General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hikma Pharmaceuticals General Anaesthetic Medication Product Portfolio
  12. 7.2.5 Hikma Pharmaceuticals Recent Developments
  13. 7.3 Maruishi
  14. 7.3.1 Maruishi Company Information
  15. 7.3.2 Maruishi Business Overview
  16. 7.3.3 Maruishi General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Maruishi General Anaesthetic Medication Product Portfolio
  18. 7.3.5 Maruishi Recent Developments
  19. 7.4 Piramal
  20. 7.4.1 Piramal Company Information
  21. 7.4.2 Piramal Business Overview
  22. 7.4.3 Piramal General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Piramal General Anaesthetic Medication Product Portfolio
  24. 7.4.5 Piramal Recent Developments
  25. 7.5 AbbVie
  26. 7.5.1 AbbVie Company Information
  27. 7.5.2 AbbVie Business Overview
  28. 7.5.3 AbbVie General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  29. 7.5.4 AbbVie General Anaesthetic Medication Product Portfolio
  30. 7.5.5 AbbVie Recent Developments
  31. 7.6 Baxter Healthcare
  32. 7.6.1 Baxter Healthcare Company Information
  33. 7.6.2 Baxter Healthcare Business Overview
  34. 7.6.3 Baxter Healthcare General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Baxter Healthcare General Anaesthetic Medication Product Portfolio
  36. 7.6.5 Baxter Healthcare Recent Developments
  37. 7.7 B.Braun
  38. 7.7.1 B.Braun Company Information
  39. 7.7.2 B.Braun Business Overview
  40. 7.7.3 B.Braun General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  41. 7.7.4 B.Braun General Anaesthetic Medication Product Portfolio
  42. 7.7.5 B.Braun Recent Developments
  43. 7.8 Fresenius-Kabi
  44. 7.8.1 Fresenius-Kabi Company Information
  45. 7.8.2 Fresenius-Kabi Business Overview
  46. 7.8.3 Fresenius-Kabi General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Fresenius-Kabi General Anaesthetic Medication Product Portfolio
  48. 7.8.5 Fresenius-Kabi Recent Developments
  49. 7.9 Hengrui
  50. 7.9.1 Hengrui Company Information
  51. 7.9.2 Hengrui Business Overview
  52. 7.9.3 Hengrui General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hengrui General Anaesthetic Medication Product Portfolio
  54. 7.9.5 Hengrui Recent Developments
  55. 7.10 Nhwa
  56. 7.10.1 Nhwa Company Information
  57. 7.10.2 Nhwa Business Overview
  58. 7.10.3 Nhwa General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Nhwa General Anaesthetic Medication Product Portfolio
  60. 7.10.5 Nhwa Recent Developments
  61. 7.11 Xi'an Libang
  62. 7.11.1 Xi'an Libang Company Information
  63. 7.11.2 Xi'an Libang Business Overview
  64. 7.11.3 Xi'an Libang General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Xi'an Libang General Anaesthetic Medication Product Portfolio
  66. 7.11.5 Xi'an Libang Recent Developments
  67. 7.12 Yichang Humanwell
  68. 7.12.1 Yichang Humanwell Company Information
  69. 7.12.2 Yichang Humanwell Business Overview
  70. 7.12.3 Yichang Humanwell General Anaesthetic Medication Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Yichang Humanwell General Anaesthetic Medication Product Portfolio
  72. 7.12.5 Yichang Humanwell Recent Developments
8 North America
  1. 8.1 North America General Anaesthetic Medication Revenue (2021-2032)
  2. 8.2 North America General Anaesthetic Medication Revenue by Type (2021-2032)
  3. 8.2.1 North America General Anaesthetic Medication Revenue by Type (2021-2026)
  4. 8.2.2 North America General Anaesthetic Medication Revenue by Type (2027-2032)
  5. 8.3 North America General Anaesthetic Medication Revenue Share by Type (2021-2032)
  6. 8.4 North America General Anaesthetic Medication Revenue by Application (2021-2032)
  7. 8.4.1 North America General Anaesthetic Medication Revenue by Application (2021-2026)
  8. 8.4.2 North America General Anaesthetic Medication Revenue by Application (2027-2032)
  9. 8.5 North America General Anaesthetic Medication Revenue Share by Application (2021-2032)
  10. 8.6 North America General Anaesthetic Medication Revenue by Country
  11. 8.6.1 North America General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America General Anaesthetic Medication Revenue by Country (2021-2026)
  13. 8.6.3 North America General Anaesthetic Medication Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe General Anaesthetic Medication Revenue (2021-2032)
  2. 9.2 Europe General Anaesthetic Medication Revenue by Type (2021-2032)
  3. 9.2.1 Europe General Anaesthetic Medication Revenue by Type (2021-2026)
  4. 9.2.2 Europe General Anaesthetic Medication Revenue by Type (2027-2032)
  5. 9.3 Europe General Anaesthetic Medication Revenue Share by Type (2021-2032)
  6. 9.4 Europe General Anaesthetic Medication Revenue by Application (2021-2032)
  7. 9.4.1 Europe General Anaesthetic Medication Revenue by Application (2021-2026)
  8. 9.4.2 Europe General Anaesthetic Medication Revenue by Application (2027-2032)
  9. 9.5 Europe General Anaesthetic Medication Revenue Share by Application (2021-2032)
  10. 9.6 Europe General Anaesthetic Medication Revenue by Country
  11. 9.6.1 Europe General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe General Anaesthetic Medication Revenue by Country (2021-2026)
  13. 9.6.3 Europe General Anaesthetic Medication Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China General Anaesthetic Medication Revenue (2021-2032)
  2. 10.2 China General Anaesthetic Medication Revenue by Type (2021-2032)
  3. 10.2.1 China General Anaesthetic Medication Revenue by Type (2021-2026)
  4. 10.2.2 China General Anaesthetic Medication Revenue by Type (2027-2032)
  5. 10.3 China General Anaesthetic Medication Revenue Share by Type (2021-2032)
  6. 10.4 China General Anaesthetic Medication Revenue by Application (2021-2032)
  7. 10.4.1 China General Anaesthetic Medication Revenue by Application (2021-2026)
  8. 10.4.2 China General Anaesthetic Medication Revenue by Application (2027-2032)
  9. 10.5 China General Anaesthetic Medication Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia General Anaesthetic Medication Revenue (2021-2032)
  2. 11.2 Asia General Anaesthetic Medication Revenue by Type (2021-2032)
  3. 11.2.1 Asia General Anaesthetic Medication Revenue by Type (2021-2026)
  4. 11.2.2 Asia General Anaesthetic Medication Revenue by Type (2027-2032)
  5. 11.3 Asia General Anaesthetic Medication Revenue Share by Type (2021-2032)
  6. 11.4 Asia General Anaesthetic Medication Revenue by Application (2021-2032)
  7. 11.4.1 Asia General Anaesthetic Medication Revenue by Application (2021-2026)
  8. 11.4.2 Asia General Anaesthetic Medication Revenue by Application (2027-2032)
  9. 11.5 Asia General Anaesthetic Medication Revenue Share by Application (2021-2032)
  10. 11.6 Asia General Anaesthetic Medication Revenue by Country
  11. 11.6.1 Asia General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia General Anaesthetic Medication Revenue by Country (2021-2026)
  13. 11.6.3 Asia General Anaesthetic Medication Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA General Anaesthetic Medication Revenue (2021-2032)
  2. 12.2 SAMEA General Anaesthetic Medication Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA General Anaesthetic Medication Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA General Anaesthetic Medication Revenue by Type (2027-2032)
  5. 12.3 SAMEA General Anaesthetic Medication Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA General Anaesthetic Medication Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA General Anaesthetic Medication Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA General Anaesthetic Medication Revenue by Application (2027-2032)
  9. 12.5 SAMEA General Anaesthetic Medication Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA General Anaesthetic Medication Revenue by Country
  11. 12.6.1 SAMEA General Anaesthetic Medication Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA General Anaesthetic Medication Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA General Anaesthetic Medication Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst